CardioCAPS

Co-financing from the state budget from the Medical Research Agency

Project: Increasing drug safety by implementing Celon Pharma S.A. in its own production innovative oral forms of three medicinal products used in the pharmacotherapy of cardiovascular diseases.

Agreement No.: 2022/ABM/04/000001 - 00

The aim of the project "CardioCAPS - Increasing drug safety by implementing Celon Pharma S.A. in its own production of innovative oral forms of three medicinal products used in the pharmacotherapy of cardiovascular diseases” is to increase the availability of pharmacotherapy for cardiovascular diseases, which are a key therapeutic area for public health. The goal will be achieved by developing new generic products (in a distinctive hard capsule form), performing clinical bioequivalence studies and implementing a comprehensive portfolio of three new generation anticoagulants in our own production.

Co-financing value: PLN 12,111,201.12

The total cost of the project: PLN 19,560,952.10